Zenith Drugs Limited Share Price & Stock Analysis

Zenith Drugs Limited (NSE: ZENITHDRUG) is an Indore, Madhya Pradesh-based company in the Pharmaceuticals industry. With a market capitalisation of ₹68 Cr, it ranks #3,567 by market cap among the 6,197 Indian listed companies on FinBizNet, and #49 of 63 in Pharmaceuticals. At ₹42.85 (as of 16 Nov 2026), the share price is 28.2% below its 52-week high of ₹59.65 and 28.7% above its 52-week low of ₹33.30. The share price is down 32.1% over one year and down 3.0% over three months.

Key Metrics

Current Price₹42.85
Market Cap₹68 Cr
NSE SymbolZENITHDRUG
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Pharmaceuticals
P/E Ratio18.6
Return on Equity5.52%
Return on Assets3.47%
52-Week Range₹33.30 – ₹59.65
1-Year Price Change-32.1%
3-Month Price Change-3.0%
Beta (1Y)0.71
Dividend Yield0.00%
HeadquartersIndore, Madhya Pradesh
Websitezenithdrugs.com

Shareholding and Delivery

Promoters held 69.98% of Zenith Drugs Limited's shares as of Mar 2026, unchanged from Mar 2025.

About Zenith Drugs Limited

Zenith Drugs Limited, together with its subsidiaries, manufactures and trades in branded, generic, and OTC medicines. The company offers a range of pharmaceutical formulations, such as ORS powder, liquid orals, ointments, creams, gels, liquid externals, capsules, and tablets. Its products are indicated for allergology, general analytics, infections, genetics, endocrinology, and microbiology. The company operates in India, Costa Rica, Mauritius, Cambodia, Myanmar, Yemen, Sierra, Leone, Liberia, and Bhutan. Zenith Drugs Limited was incorporated in 1956 and is based in Indore, India.

Products and Services

1. Manufacturing and Trading of Medicines-This segment engages in manufacturing and trading medicines. 2. NA-NA 3. NA-NA 4. NA-NA

Business Segments

1. Manufacturing and Trading of Medicines-100%

Zenith Drugs Limited vs Peers — Pharmaceuticals

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Abbott India Ltd.₹56,531 Cr36.334.46%₹1,814 Cr-8.1%
Emcure Pharmaceuticals Ltd₹42,344 Cr47.919.57%₹2,820 Cr+73.3%
Ajanta Pharma Limited₹41,474 Cr39.425.39%₹1,794 Cr+27.8%
Piramal Pharma Ltd₹32,600 Crn/m-4.00%₹2,617 Cr+22.8%
RUBICON RESEARCH LIMITED₹28,526 Cr112.319.14%₹576 Cr+162.7%
Caplin Point Laboratories Ltdte₹18,155 Cr28.319.94%₹630 Cr+23.6%
Pfizer Ltd.₹17,811 Cr24.517.16%₹727 Cr-24.2%
Eris Lifesciences Ltd₹17,691 Cr28.318.07%₹892 Cr-17.5%
Zenith Drugs Limited₹68 Cr18.65.52%—-32.1%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Zenith Drugs Limited?

Zenith Drugs Limited is trading at ₹42.85, with a market capitalisation of ₹68 Cr.

Which sector does Zenith Drugs Limited belong to?

Zenith Drugs Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).

What are the key financial ratios of Zenith Drugs Limited?

Zenith Drugs Limited has a P/E of 18.6 and a return on equity of 5.52%.

What is the stock symbol of Zenith Drugs Limited?

Zenith Drugs Limited is listed on the NSE under the symbol ZENITHDRUG.

How has Zenith Drugs Limited's share price moved over the past year?

Zenith Drugs Limited's share price is down 32.1% over one year and down 3.0% over three months. Its 52-week range is ₹33.30 to ₹59.65.

What is the promoter holding in Zenith Drugs Limited?

Promoters held 69.98% of Zenith Drugs Limited's shares as of Mar 2026, unchanged from Mar 2025.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.